Author:
Yadav Mange Ram,Murumkar Prashant R.,Joshi Karan,Barot Rahul,Yadav Rasana
Publisher
Springer Nature Singapore
Reference49 articles.
1. Agatonovic-Kustrin S, Kettle C, Morton DW (2018) A molecular approach in drug development for Alzheimer’s disease. Biomed Pharmacother 106:553–565
2. Asadipour A, Alipour M, Jafari M, Khoobi M, Emami S, Nadri H, Sakhteman A, Moradi A, Sheibani V, Homayouni Moghadam F, Shafiee A, Foroumadi A (2013) Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors. Eur J Med Chem 70:623–630. https://doi.org/10.1016/j.ejmech.2013.10.024
3. Ashraf GM, Tarasov VV, Makhmutovа A, Chubarev VN, Avila-Rodriguez M, Bachurin SO, Aliev G (2019) The possibility of an infectious etiology of Alzheimer disease. Mol Neurobiol 56(6):4479–4491. https://doi.org/10.1007/s12035-018-1388-y
4. Barmade M, Shidore M, Rajyaguru S, Machhi J, Murumkar P, Yadav MR (2017) Design and development of pramipexole-donepezil hybrids as potential therapeutics for Alzheimer’s disease. Amer Chemical Soc 254
5. Bar-On P, Millard CB, Harel M, Dvir H, Enz A, Sussman JL, Silman I (2002) Kinetic and structural studies on the interaction of Cholinesterases with the anti-Alzheimer drug Rivastigmine. Biochemistry 41(11):3555–3564